Live Science on MSN
'Groundbreaking' gene therapy is first treatment for Huntington's disease to slow the condition
Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the ...
1don MSN
Q&A: How do humans control their bodies, and what does it mean for Parkinson's disease risk?
How humans move is an open question, according to Mark Latash, distinguished professor of kinesiology at Penn State.
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to ...
Personalized, at-home, adaptive deep brain stimulation is safe and effective for patients with moderate-to-advanced Parkinson ...
A recent trial published in the Journal of American Medical Association found that subthalamic deep brain stimulation (DBS) ...
BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...
Susanne Morton has spent more than two decades studying motor learning. Morton is an associate professor in the Department of Physical Therapy (PT) at the University of Delaware’s College of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback